Cimzia® (certolizumab pegol),
due to its unique Fc-free
structure, showed zero to
minimal placental transfer
from mother to baby.1*
*The available clinical experience is too limited to conclude that there
is no increased risk associated with Cimzia administration during pregnancy.
Cimzia should only be used during pregnancy if clinically needed.